静脉注射白消安、二甲基乙酰胺与大剂量移植前预处理化疗后的神经毒性 - Suppr

Suppr

超能文献

Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy.

作者信息

Ramdial J, Chan K H, Sanchez Petitto G, Valdez B, Andersson B S, Nieto Y

机构信息

Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Bone Marrow Transplant. 2023 Jun;58(6):635-638. doi: 10.1038/s41409-023-01964-y. Epub 2023 Mar 25.

DOI:10.1038/s41409-023-01964-y

PMID:36966213

Abstract

摘要

相似文献

Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy.静脉注射白消安、二甲基乙酰胺与大剂量移植前预处理化疗后的神经毒性

Bone Marrow Transplant. 2023 Jun;58(6):635-638. doi: 10.1038/s41409-023-01964-y. Epub 2023 Mar 25.

Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.造血细胞移植患者用白消安进行清髓性和非清髓性/低强度预处理后发生的消化道黏膜炎的回顾性研究。

Support Care Cancer. 2019 Mar;27(3):839-848. doi: 10.1007/s00520-018-4362-3. Epub 2018 Aug 14.

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study.静脉注射白消安与口服白消安及环磷酰胺联合用于移植前预处理治疗时的急性安全性和药代动力学：一项I期研究。

Biol Blood Marrow Transplant. 2000;6(5A):548-54. doi: 10.1016/s1083-8791(00)70064-4.

Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation.在接受干细胞移植的患者中，基于白消安的预处理方案在未进行预防的情况下神经毒性发生率极低。

Int J Hematol. 2016 Dec;104(6):644-646. doi: 10.1007/s12185-016-2098-8. Epub 2016 Oct 8.

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.异基因造血干细胞移植前基于白消安的静脉预处理：毒性降低的清髓治疗。

Exp Hematol. 2003 May;31(5):428-34. doi: 10.1016/s0301-472x(03)00047-x.

The importance of therapeutic drug monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for hematopoietic stem cell transplantation (HSCT) in children.治疗药物监测（TDM）在儿童造血干细胞移植（HSCT）预处理方案中静脉注射白消安剂量方面的重要性。

Ann Transplant. 2014 May 9;19:214-24. doi: 10.12659/AOT.889933.

Primary adrenal insufficiency in a child after busulfan and cyclophosphamide-based conditioning for hematopoietic stem cell transplantation.在接受基于白消安和环磷酰胺的预处理进行造血干细胞移植后的儿童中发生的原发性肾上腺功能不全。

J Pediatr Endocrinol Metab. 2011;24(9-10):853-5. doi: 10.1515/jpem.2011.131.

A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia.一项关于靶向、剂量递增静脉注射白消安联合依托泊苷作为急性髓性白血病自体干细胞移植清髓疗法的I期研究。

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):377-83. doi: 10.1016/j.clml.2015.02.016. Epub 2015 Feb 14.

Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.静脉注射白消安暴露程度与接受清髓性异基因造血细胞移植的儿童和青年成人肝静脉闭塞病发展的相关性。

Transplant Cell Ther. 2022 Apr;28(4):196-202. doi: 10.1016/j.jtct.2022.01.013. Epub 2022 Jan 19.

Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation.静脉注射白消安试验剂量的药代动力学指导剂量调整，以在接受造血干细胞移植的低强度预处理方案的儿童中实现每日单次静脉注射白消安的最佳曲线下面积。

Biol Blood Marrow Transplant. 2006 Apr;12(4):472-9. doi: 10.1016/j.bbmt.2005.12.028.

本文引用的文献

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.在多发性骨髓瘤自体造血细胞移植前，白消安加美法仑与单用美法仑进行预处理的比较：一项开放标签、随机、3期试验。

Lancet Haematol. 2019 May;6(5):e266-e275. doi: 10.1016/S2352-3026(19)30023-7. Epub 2019 Mar 22.

High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan.高剂量吉西他滨、白消安和马法兰用于复发或难治性骨髓瘤患者的自体干细胞移植：一项2期试验及与马法兰的配对比较

Lancet Haematol. 2017 Jun;4(6):e283-e292. doi: 10.1016/S2352-3026(17)30080-7. Epub 2017 May 15.

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.前瞻性队列研究比较了造血细胞移植中静脉注射白消安与全身照射。

Blood. 2013 Dec 5;122(24):3871-8. doi: 10.1182/blood-2013-08-519009. Epub 2013 Sep 30.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.与 TBI 相比，环磷酰胺联合白消安在 AML 首次缓解后可改善无白血病生存和总生存。

Blood. 2013 Dec 5;122(24):3863-70. doi: 10.1182/blood-2013-07-514448. Epub 2013 Sep 24.

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.缓解期急性髓系白血病的异基因造血干细胞移植：静脉用白消安加环磷酰胺（Cy）与全身照射加 Cy 作为预处理方案的比较——欧洲血液和骨髓移植学会急性白血病工作组的报告。

J Clin Oncol. 2013 Oct 1;31(28):3549-56. doi: 10.1200/JCO.2013.48.8114. Epub 2013 Aug 26.

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.每日一次静脉注射白消安和氟达拉滨：用于急性髓系白血病和骨髓增生异常综合征异基因干细胞移植的清髓性、低毒性预处理方案的临床和药代动力学结果

Blood. 2004 Aug 1;104(3):857-64. doi: 10.1182/blood-2004-02-0414. Epub 2004 Apr 8.

Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.骨髓移植后肝静脉闭塞病：诊断、发病率及易感因素

Hepatology. 1984 Jan-Feb;4(1):116-22. doi: 10.1002/hep.1840040121.

Venoocclusive disease of the liver following bone marrow transplantation.

Transplantation. 1987 Dec;44(6):778-83. doi: 10.1097/00007890-198712000-00011.

Developmental toxicity of dimethylacetamide by inhalation in the rat.大鼠吸入二甲基乙酰胺的发育毒性

Fundam Appl Toxicol. 1991 Apr;16(3):414-22. doi: 10.1016/0272-0590(91)90082-f.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验